Other
Caesarean Section
0
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Caesarean Section is an early-stage landscape with 0 programs across 2 companies. The most active players are Heron Therapeutics, Merz Pharmaceuticals GmbH.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
66
clinical trials
Completed43 · 65%
Unknown status17 · 26%
Withdrawn2 · 3%
Recruiting2 · 3%
Not yet recruiting1 · 2%
Terminated1 · 2%
Clinical Trials
Trial Activity
66 trials
Comparing Prophylactic Intravenous Pethidine and Intrathecal Pethidine in Preventing Post Spinal Shivering in Caesarean Section
Recruiting·—·Phase 3·NCT06775431·86 enrolled
Intrathecal MoRphine Versus Transabdominal Plane Block (TAP) Block for AnalGesic Management in Elective Caesarean Section
Not yet recruiting·—·Phase 4·NCT07377630·100 enrolled
Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine
Completed·—·Phase 4·NCT02274974·160 enrolled
Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus
Completed·—·N/A·NCT01772381·600 enrolled
Optimization of Hemodynamic Conditions During Caesarean Section Under Spinal Anaesthesia
Completed·—·N/A·NCT01278238·120 enrolled
Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section
Completed·—·Phase 1·NCT06318546·130 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)